TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Fri Jul 25

NL

Article

EBCapitalMarkets published an article 10:47 AM

Humira Still Key to AbbVie

AbbVie posted solid second-quarter results thanks to its top-selling Humira, but challenges remain from competitors such as Johnson & Johnson ahead of Humira's patent expiration.

Thu Jul 24

NL

Article

EBCapitalMarkets published an article 4:01 PM

What Gilead Stock's Latest Blockbuster Approval Means for Investors

Gilead Science's (GILD) Zydelig won approval for use in chronic lymphocytic leukemia, follicular lymphoma, and small lymphocytic lymphoma.

NL

Article

EBCapitalMarkets published an article 2:53 PM

Celgene Stock Earnings: Key Takeaways

Celgene reported solid revenue and earnings for the second quarter, which may suggest investors are wrong to sell shares.

NL

Article

EBCapitalMarkets published an article 12:47 PM

3 Crucial Quotes From Gilead Sciences Stock

Here are three quotes from Gilead Sciences (GILD) management that offer clues as to whether the companies hepatitis C and HIV drug sales will grow through year end.

Wed Jul 23

NL

Article

EBCapitalMarkets published an article 5:53 PM

Is Gilead About to Crush Pharmacyclics Stock?

Gilead (GILD) won approval for Zydelig this week as a treatment for chronic lymphocytic leukemia, but that doesn't mean that Johnson & Johnson (JNJ) and Pharmacyclics' Imbruvica is heading for the dustbin.

NL

Article

EBCapitalMarkets published an article 2:02 PM

3 Can't-Miss Quotes From UnitedHealth Group's CEO

UnitedHealth Group's (UNH) second quarter earnings conference call offers three gems that could have implications for other insurers like WellPoint (WLP).

NL

Article

EBCapitalMarkets published an article 2:00 PM

5 Novartis Drugs You Need To Know About

Biogen (BIIB) and Regeneron (REGN) pose threats to Novartis' (NVS) sales as Diovan competitors launch.

NL

Article

EBCapitalMarkets published an article 1:33 PM

Decoding 4 Stocks' Big Earnings Moves

ConMed (CNMD) shares are dropping while Quidel (QDEL), Neogen (NEOG), and Vascular Solutions (VASC) shares are gaining double digits following earnings.

NL

Article

EBCapitalMarkets published an article 11:44 AM

Biogen Stock's Tecfidera Embarrasses Wall Street

Sales of Biogen's (BIIB) MS drug Tecfidera soared again last quarter as it won market share away from competing oral MS drugs from Novartis (NVS) and Sanofi (SNY).

NL

Article

EBCapitalMarkets published an article 10:22 AM

3 Future Biotechnology Blockbusters?

Medivation, Ophthotech, and Portola all have potential blockbusters on their hands.

Tue Jul 22

NL

Article

EBCapitalMarkets published an article 5:42 PM

295% Pop: Too Late to Buy Puma Biotechnology Stock?

Puma Biotechnology (PBYI) reported surprising phase 3 data that sent shares soaring. Here's what you need to know about Puma's promising cancer drug.

NL

Article

EBCapitalMarkets published an article 12:52 PM

Could This 1 Lawsuit Destroy Biogen Idec Stock?

Sanofi (SNY) and Novartis (NVS) generic units are among those challenging the dosing patent on Biogen's (BIIB) Tecfidera.

NL

Article

EBCapitalMarkets published an article 10:57 AM

5 Key Ways for Laboratory Corp Stock to Win

Here are the five goals CEO David King thinks Laboratory Corp (LH) will need to execute on if the company hopes to grow.

Mon Jul 21

NL

Article

EBCapitalMarkets published an article 2:46 PM

Revenue Up 27%: Time to Buy Athenahealth Stock?

Athenahealth posted solid sales growth in the second quarter as it won share from Allscripts and Quality Systems, but investors are right to worry over lackluster earnings.

Thu Jul 17

NL

Article

EBCapitalMarkets published an article 10:01 PM

Obamacare's Medicaid Expansion a Slam Dunk for UnitedHealth Group

UnitedHealth Group signed up more than 380,000 new members through Medicaid in the second quarter, suggesting that similarly strong results will be posted by competitors Aetna (AET) and WellPoint (WLP)

NL

Article

EBCapitalMarkets published an article 4:18 PM

Are Insurers Playing Fair With HIV Patients?

Insurers Aetna (AET), Cigna (CI), and Humana (HUM) are on the hot seat over how much they'll pay for HIV drugs like those made by Gilead (GILD).

NL

Article

EBCapitalMarkets published an article 1:17 PM

The Implications of Obesity as a Disability in Europe

Despite rising obesity in Europe, the EU has yet to approve weight loss drugs from Arena (ARNA), Vivus (VVUS), or Orexigen (OREX).

NL

Article

EBCapitalMarkets published an article 10:37 AM

Why Growth Is Coming to Abbott Laboratories Stock

Here's what you need to know about Abbott Laboratories second-quarter results and its outlook for the rest of this year.

Wed Jul 16

NL

Article

EBCapitalMarkets published an article 6:47 PM

Everything is Bigger in Texas...Including Medicaid

Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.

NL

Article

EBCapitalMarkets published an article 4:01 PM

Is Obamacare Behind HCA Stock's Surprising Surge?

HCA (HCA) pre-released its second quarter results today, sending shares significantly higher.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 66858 out of 75003
Score -402.33
Score Change Today -13.79
Accuracy 26.47%
Active Picks 34
Total Picks 34
Best Pick GILD (+39.49)
Worst Pick WFM (-51.18)
Average Score per Pick -11.83
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts